AI Article Synopsis
- - The study aimed to identify when sentinel lymph node biopsy (SLNB) is appropriate for treating oral cancer with no lymph node involvement.
- - Researchers analyzed data from 158 patients focusing on the depth of invasion (DOI) and long diameter (LD) of tumors to determine the rates of SLN metastasis.
- - Findings showed varying SLN positivity rates based on tumor size, suggesting that SLNB could be a valuable method for managing lymph nodes in patients with oral cancer.
Article Abstract
Background: We aimed to define the indications for sentinel lymph node biopsy (SLNB), the third option for cervical treatment in oral cancer with negative cervical lymph nodes.
Methods: The greatest depth of invasion (DOI) and long diameter (LD) of the primary site were used as exposures. SLN metastasis was considered the outcome.
Results: In three trials conducted between 2009 and 2016, 158 patients were eligible and reassigned to this study group. The scatterplot based on the respective values of DOI and LD would eventually be divided into three sections. In cases of sections T1, T2, and T3, the proportions of SLN metastasis positivity were 21.3%, 35.3%, and 51.2%, respectively. In certain cases of T1 with 2 mm < DOI ≤ 5 mm and 8 mm < LD ≤ 20 mm, the proportion of SLN metastasis positivity was 40.9%.
Conclusions: SLNB-navigated or assisted neck dissection can be added as an effective procedure for N0 neck control.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hed.27477 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!